Delivery Order SPE2DB22D3501-SPE2DB24FUL21
Award Date
2/2/24
Potential Completion Date
2/5/24
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4563867821 - BUPROPION HCL XL 300 MG TABLET 500S. The contract has a potential value of $14,307.61 and a completion date of March 6, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $37,884.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564205437 - Bupropion HCL XL 300 mg tablets in 500 count bottles. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,928 bupropion HCL XL 300 mg tablets in 500-count bottles. The $2,160 contract has an ultimate completion date of April 12, 2024 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, the prime contractor, is the sole awardee on this delivery order, which is issued against a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide 4,563,618,722 Bupropion HCL XL 300 mg tablets in quantities of 500 per bottle. The $20,759.83 delivery order has a completion date of February 12, 2024 and was awarded on February 9, 2024. This award is part of a larger indefinite delivery contract (IDC) that...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,303.64 to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The contract is to provide 4564006464 - Bupropion HCL XL 300 mg tablets in 500-count containers. The delivery order contract has a performance period through March 20, 2024 and does not have a set-aside designation. This delivery order is issued under a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $31,697.41 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,154,812 units of bupropion HCL XL 300 mg tablets. The contract has an ultimate completion date of December 21, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,262,033 units of Bupropion HCL XL 150 mg tablets. The $10,933.71 contract has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,134 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $42,999.30 and a performance period through April 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,981,532 tablets of Bupropion HCL XL 300 mg. The order, valued at $4,027.25, has a performance period through March 18, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of...